Similarly, for EC, 5‐year survival was more than 20% lower for women with tumor block expression of p16 (63.0%, SE 5.8%) compared to heterogeneous staining (85.0%, SE 1.4%, p < 0.0001, Figure 1F) or absent staining (85.2%, SE 3.3). Here, CDKN2A is linked to neoplasm.